Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2016-12-22

Clinical Trial Update: Comparison of Antibody Levels in Children and Adolescents After Initiation of Insulin Therapy by Either Insulin Aspart or Soluble Human Insulin [NA]

View source ↗

Summary

A clinical trial update reports on antibody levels after initiation of insulin therapy using insulin aspart or regular human insulin in children and adolescents…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Insulin aspart (insulin aspart)
  • Regular human insulin (human insulin (regular))

Snippet

Sponsor: Novo Nordisk A/S | Conditions: Diabetes, Diabetes Mellitus, Type 1 | NA | Status: COMPLETED